Stuart D.C. Ward

Statistics

Publications

Citations

629

H-Index

Active since

1995

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

Medical Research Council

National Institutes of Health

Stuart D.C. Ward is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in muscarinic receptors, cell signaling, and pharmacology.

Publications per year

1995–2008

Publications

BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors

Aaron S. Goetz, Holly K. King, Stuart D.C. Ward et al. · European Journal of Pharmacology · 1995 · 302 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Conformational Changes That Occur during M3Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross-linking Strategy

Stuart D.C. Ward, Fadi F. Hamdan, Lanh M. Bloodworth et al. · Journal of Biological Chemistry · 2002 · 78 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Alanine-Scanning Mutagenesis of Transmembrane Domain 6 of the M<sub>1</sub>Muscarinic Acetylcholine Receptor Suggests that Tyr381 Plays Key Roles in Receptor Function

Stuart D.C. Ward, C.A.M. Curtis, Edward C. Hulme · Molecular Pharmacology · 1999 · 67 citations

Medicine, Pharmacology, Cell Signaling +16

Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers

Lars J. S. Knutsen, Chris Hobbs, Christopher G. Earnshaw et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity

Robin D. Clark, Nicholas C. Ray, Karen Williams et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

1–5 of 8